ConductScience.org, home

Paper29972754

Chimeric Antigen Receptor Therapy.

June CH and 1 other. N Engl J Med, 2018. Cited by 1,883 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Chimeric Antigen Receptor Therapy. Papers, record 29972754. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29972754

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Chimeric Antigen Receptor Therapy.
PubMed
Journal
N Engl J Med
PubMed
Year
2018
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1,883
iCite
Relative citation ratio, by iCite
60.7
iCite
Revised in PubMed
2023-06-07
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1June CHCarl Hhttps://orcid.org/0000-0003-0241-3557
2Sadelain MMichel

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adoptive TransferMajor topic
NeoplasmsMajor topic
Receptors, Antigen, T-CellMajor topic
Recombinant Fusion ProteinsMajor topic
T-LymphocytesMajor topic
Antigens, CD19
Genetic Engineering
Humans
Remission Induction

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
P01 CA214278NCI NIH HHSUnited StatesP01CA214278PubMed

Source NIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT07390071Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell ImmunotherapyBackground

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in29972760A Look Forward - The Frontiers in Medicine Series.https://conductscience.org/library/papers/29972760

Source PubMed

Download CSV of comments and corrections

References83

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127076371Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia.Cancer Discov2016https://conductscience.org/library/papers/27076371PubMed
226333935Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia.Sci Transl Med2015https://conductscience.org/library/papers/26333935PubMed
326461090Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells.Cancer Cell2015https://conductscience.org/library/papers/26461090PubMed
417855649Genetically targeted T cells eradicate systemic acute lymphoblastic leukemia xenografts.Clin Cancer Res2007https://conductscience.org/library/papers/17855649PubMed
526516065Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy.Cancer Discov2015https://conductscience.org/library/papers/26516065PubMed
629385370Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.N Engl J Med2018https://conductscience.org/library/papers/29385370PubMed
724597865Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.N Engl J Med2014https://conductscience.org/library/papers/24597865PubMed
823247726T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production.Blood2013https://conductscience.org/library/papers/23247726PubMed
926875830Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease.Nat Rev Immunol2016https://conductscience.org/library/papers/26875830PubMed
1018688285Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1.J Clin Invest2008https://conductscience.org/library/papers/18688285PubMed
1124876563Current concepts in the diagnosis and management of cytokine release syndrome.Blood2014https://conductscience.org/library/papers/24876563PubMed
1218026115T cell-encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection.Nat Med2007https://conductscience.org/library/papers/18026115PubMed
1322553251Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells.Sci Transl Med2012https://conductscience.org/library/papers/22553251PubMed
1422935759The determination and interpretation of the therapeutic index in drug development.Nat Rev Drug Discov2012https://conductscience.org/library/papers/22935759PubMed
1524553386Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia.Sci Transl Med2014https://conductscience.org/library/papers/24553386PubMed
1628106152Cancer immunotherapy - immune checkpoint blockade and associated endocrinopathies.Nat Rev Endocrinol2017https://conductscience.org/library/papers/28106152PubMed
1721830940Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia.N Engl J Med2011https://conductscience.org/library/papers/21830940PubMed
183264384Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report.N Engl J Med1988https://conductscience.org/library/papers/3264384PubMed
1924777247T cells expressing chimeric antigen receptors can cause anaphylaxis in humans.Cancer Immunol Res2013https://conductscience.org/library/papers/24777247PubMed
2028029927Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy.N Engl J Med2016https://conductscience.org/library/papers/28029927PubMed

See all 83 referencesDownload CSV of references

Cited by1,374

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,883 citations.

PMIDTitleJournalYearIn PapersSource
42978867Engineering ex vivo T-cell expansion for CAR-T therapy: bridging biological fidelity and bioprocess scalability through platforms, functional consumables, and integrated closed manufacturing.Front Immunol2026https://conductscience.org/library/papers/42978867PubMed
42973514Patient-derived high functional avidity TCR empowers diverse T cell subsets for tumour immunotherapy.Front Immunol2026https://conductscience.org/library/papers/42973514PubMed
42963425BAZ2A-induced epigenetic states in cancer cells fuel palmitate accumulation in the tumor microenvironment driving CAR-T cell exhaustion.Nat Cancer2026https://conductscience.org/library/papers/42963425PubMed
42961140An Orthotopic Xenograft Model for Preclinical Evaluation of CAR T Cell Therapy in Glioblastoma.Curr Protoc2026https://conductscience.org/library/papers/42961140PubMed
42942996Pretreatment Prognostic Nutritional Index Is Associated with Treatment Response and Survival in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma Receiving CAR-T Cell Therapy.Nutrients2026https://conductscience.org/library/papers/42942996PubMed
42936601CAR-T-cell therapy for autoimmune neurologic diseases.Front Immunol2026https://conductscience.org/library/papers/42936601PubMed
42935498Gene therapy as an upcoming technique in the treatment of cancer: A cellular solution to a cellular problem.Mol Ther Oncol2026https://conductscience.org/library/papers/42935498PubMed
42924291Universal CAR-T cell therapy: overcoming key hurdles on the path to off-the-shelf adoption.Med Rev (2021)2026https://conductscience.org/library/papers/42924291PubMed
42909179Mapping programmable mRNA research relevant to cancer-associated immune escape: a dual-database bibliometric and topic modeling analysis.Front Oncol2026https://conductscience.org/library/papers/42909179PubMed
42905219Cardiovascular Toxicity Across the Cancer Immunotherapy Spectrum: Mechanisms and Management in Immune Checkpoint Inhibitor (ICI) and Chimeric Antigen Receptor T-Cell (CAR-T) Therapy.Curr Oncol Rep2026https://conductscience.org/library/papers/42905219PubMed
42898905Epigenetic and metabolic plasticity of tumor cells in immunotherapy resistance.Front Immunol2026https://conductscience.org/library/papers/42898905PubMed
42898688Advances and applications of engineered protein therapeutics and their role in precision medicine.Front Bioeng Biotechnol2026https://conductscience.org/library/papers/42898688PubMed
42898659Application of CAR-T cell therapy in orthopedics: From bone malignancies to non-malignant musculoskeletal disorders.J Orthop Translat2026https://conductscience.org/library/papers/42898659PubMed
42898640Why only 3 months? Immunological constraints on CAR-T therapy in gastrointestinal cancers.Front Immunol2026https://conductscience.org/library/papers/42898640PubMed
42898508An integrative meningioma surfaceome atlas and a transferable framework for CAR-T target nomination.Front Bioinform2026https://conductscience.org/library/papers/42898508PubMed
42894261Evolution of CAR-T Therapy: Functional Engineering, Manufacturing Innovation, and Future In Vivo Strategies.Cancer Sci2026https://conductscience.org/library/papers/42894261PubMed
42890243Model-based integration of chimeric antigen receptor T-cell kinetics and tumor features to predict therapeutic outcomes in patients with B-cell malignancies.Front Immunol2026https://conductscience.org/library/papers/42890243PubMed
42888448CAR-T-centered sequential therapy: current status, challenges, and future clinical perspectives.J Hematol Oncol2026https://conductscience.org/library/papers/42888448PubMed
42884102Bench-to-Bedside Perspectives on the Development of Soluble TCR-Based Protein Biologics: Current Landscape, Control Strategy and Future Direction.Int J Mol Sci2026https://conductscience.org/library/papers/42884102PubMed
42881857
Molecularly Guided Therapy and the Tumor Microenvironment in Advanced Cholangiocarcinoma: Current Evidence and Emerging Strategies Targeting FGFR2, HER2, and IDH1 with Pemigatinib, Zanidatamab, and Ivosidenib.
J Clin Med2026https://conductscience.org/library/papers/42881857PubMed

See all 1,374 cited byDownload CSV of cited by

Genes31

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ADGRE230817PubTator's text mininghttps://conductscience.org/library/genes/30817NCBI Gene
CARS1833PubTator's text mininghttps://conductscience.org/library/genes/833NCBI Gene
CARTPT9607PubTator's text mininghttps://conductscience.org/library/genes/9607NCBI Gene
CASP9842PubTator's text mininghttps://conductscience.org/library/genes/842NCBI Gene
CD19930PubTator's text mininghttps://conductscience.org/library/genes/930NCBI Gene
CD22933PubTator's text mininghttps://conductscience.org/library/genes/933NCBI Gene
CD247919PubTator's text mininghttps://conductscience.org/library/genes/919NCBI Gene
CD28940PubTator's text mininghttps://conductscience.org/library/genes/940NCBI Gene
CD33945PubTator's text mininghttps://conductscience.org/library/genes/945NCBI Gene
CD38952PubTator's text mininghttps://conductscience.org/library/genes/952NCBI Gene
CD70970PubTator's text mininghttps://conductscience.org/library/genes/970NCBI Gene
CEACAM51048PubTator's text mininghttps://conductscience.org/library/genes/1048NCBI Gene
CLEC12A160364PubTator's text mininghttps://conductscience.org/library/genes/160364NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
FOLR22350PubTator's text mininghttps://conductscience.org/library/genes/2350NCBI Gene
HAVCR284868PubTator's text mininghttps://conductscience.org/library/genes/84868NCBI Gene
HLA-A3105PubTator's text mininghttps://conductscience.org/library/genes/3105NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
IL13RA23598PubTator's text mininghttps://conductscience.org/library/genes/3598NCBI Gene
IL2RG3561PubTator's text mininghttps://conductscience.org/library/genes/3561NCBI Gene

See all 31 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29972754

GET https://conductscience.org/api/papers/v1/29972754/references?page=2